Drug Shortage Report for TEVA-PREGABALIN
| Report ID | 162265 |
| Drug Identification Number | 02361221 |
| Brand name | TEVA-PREGABALIN |
| Common or Proper name | PREGABALIN 225MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 225MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-06-10 |
| Estimated end date | Unknown |
| Actual end date | 2023-06-08 |
| Shortage status | Resolved |
| Updated date | 2023-06-09 |
| Company comments | Trans to diff pkg size |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-06-09 | English | Compare |
| v5 | 2023-06-08 | French | Compare |
| v4 | 2023-06-08 | English | Compare |
| v3 | 2022-06-11 | English | Compare |
| v2 | 2022-06-09 | French | Compare |
| v1 | 2022-06-09 | English | Compare |
Showing 1 to 6 of 6